Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 2/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.44 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7462866 | 1.00 | MTNR1A (0.50) | MTNR1AMTNR1BCYP19A1PRMT1AKR1C1 | |
| SCHEMBL6325877 | 0.83 | NQO2 (0.51) | — | |
| SCHEMBL6325874 | 0.83 | NQO2 (0.51) | — | |
| SCHEMBL3577068 | 0.83 | HDAC3 (0.53) | MTNR1AMTNR1BCYP19A1PRMT1AKR1C1 | |
| SCHEMBL3577074 | 0.83 | HDAC3 (0.53) | MTNR1AMTNR1BCYP19A1PRMT1AKR1C1 | |
| SCHEMBL3577072 | 0.83 | HDAC3 (0.53) | MTNR1AMTNR1BCYP19A1PRMT1AKR1C1 | |
| SCHEMBL4614326 | 0.82 | MTNR1A (0.53) | MTNR1AMTNR1BCYP19A1AKR1C1ESR1 | |
| SCHEMBL4614904 | 0.82 | MTNR1A (0.53) | MTNR1AMTNR1BCYP19A1AKR1C1ESR1 | |
| SCHEMBL11527446 | 0.81 | HDAC1 (0.42) | MTNR1AMTNR1BHDAC3HDAC1HDAC2 | |
| SCHEMBL11527443 | 0.81 | HDAC1 (0.42) | MTNR1AMTNR1BHDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1235776-A1 | TRIPHENYLALKENE DERIVATIVES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS | Hormos Medical Corporation (FI) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001036360-A1 | TRIPHENYLALKENE DERIVATIVES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS | HORMOS MEDICAL CORPORATION (FI) | 2001-05-25 | — | — | WO | disclosed |